{"article_title": "Study Warns of Alzheimer\u2019s Risk in Some Prostate-Cancer Drugs", "article_keywords": ["risk", "cancer", "twice", "drugs", "study", "disease", "alzheimers", "treatments", "testosteroneblocking", "treat", "therapyalso", "using", "prostatecancer", "prostate", "warns"], "article_url": "http://www.wsj.com/articles/study-warns-of-alzheimers-risk-in-some-prostate-cancer-drugs-1449527063", "article_text": "Men taking testosterone-blocking drugs to treat prostate cancer have nearly twice the risk of developing Alzheimer\u2019s disease as those using other treatments, according to an analysis of electronic medical records published Monday.\n\nAndrogen-deprivation therapy\u2014also known as chemical castration\u2014lowers levels of testosterone and other male hormones that can fuel the growth of prostate cancer. However, it has been linked to a higher risk of cardiovascular disease, diabetes, high cholesterol, impotence, loss of muscle mass,...", "article_metadata": {"article.template": "snippet", "article.created": "2015-12-07T22:24:00.000Z", "article.section": "US", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "Men taking testosterone-blocking drugs to treat prostate cancer have nearly twice the risk of developing Alzheimer\u2019s disease as those using other treatments, according to an analysis published Monday.", "creator": "@MelindaBeckWSJ", "image": {"alt": "Testosterone-blocking drugs for prostate cancer pose Alzheimer\u2019s risk, study finds", "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif"}, "title": "Study Warns of Alzheimer\u2019s Risk in Some Prostate-Cancer Drugs", "site": "@WSJ", "card": "summary"}, "al": {"ios": {"url": "wsj://launch?articleid=SB11818608491931414669104581402292623596886&headline=Testosterone-blocking%20drugs%20for%20prostate%20cancer%20pose%20Alzheimer%u2019s%20risk%2C%20study%20finds&weburl=http://www.wsj.com/articles/SB11818608491931414669104581402292623596886"}}, "page.site.product": "WSJ", "keywords": "alzheimer's disease,anti-androgen drugs,chemical castration,metastatic prostate cancer,research,development,corporate,industrial news,cancer,political,general news,dementia,demographic health,health,medical conditions,mental health,men's health,medical treatments,procedures,pharmaceuticals,health care,life sciences,specialized drugs,medications,hormone products", "news_keywords": "alzheimer's disease,anti-androgen drugs,chemical castration,metastatic prostate cancer,research,development,corporate,industrial news,cancer,political", "article.headline": "Testosterone-blocking drugs for prostate cancer pose Alzheimer\u2019s risk, study finds", "description": "Men taking testosterone-blocking drugs to treat prostate cancer have nearly twice the risk of developing Alzheimer\u2019s disease as those using other treatments, according to an analysis published Monday.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB11818608491931414669104581402292623596886&headline=Testosterone-blocking%20drugs%20for%20prostate%20cancer%20pose%20Alzheimer%u2019s%20risk%2C%20study%20finds&weburl=http://www.wsj.com/articles/SB11818608491931414669104581402292623596886", "user.type": "nonsubscriber", "article.page": "US", "page.content.format": "responsive", "article.summary": "Men taking testosterone-blocking drugs to treat prostate cancer have nearly twice the risk of developing Alzheimer\u2019s disease as those using other treatments, according to an analysis published Monday.", "page.site": "wsj", "testkeys": "C", "article.published": "2015-12-08T00:42:00.000Z", "dj.asn": "i-c641", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"internal_link_count": 1, "image_count": 1, "word_count": 674, "publisher": "https://www.facebook.com/wsj"}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "Men taking testosterone-blocking drugs to treat prostate cancer have nearly twice the risk of developing Alzheimer\u2019s disease as those using other treatments, according to an analysis published Monday.", "title": "Study Warns of Alzheimer\u2019s Risk in Some Prostate-Cancer Drugs", "url": "http://www.wsj.com/articles/study-warns-of-alzheimers-risk-in-some-prostate-cancer-drugs-1449527063", "image": {"width": 1200, "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif", "height": 630}, "locale": "en_US", "type": "article"}, "author": "Melinda Beck", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "Study Warns of Alzheimer\u2019s Risk in Some Prostate-Cancer Drugs", "article.type": "U.S. News", "article.id": "SB11818608491931414669104581402292623596886", "user.exp": "default", "article.updated": "2015-12-08T00:42:00.000Z"}, "article_summary": "Men taking testosterone-blocking drugs to treat prostate cancer have nearly twice the risk of developing Alzheimer\u2019s disease as those using other treatments, according to an analysis of electronic medical records published Monday.\nAndrogen-deprivation therapy\u2014also known as chemical castration\u2014lowers levels of testosterone and other male hormones that can fuel the growth of prostate cancer.\nHowever, it has been linked to a higher risk of cardiovascular disease, diabetes, high cholesterol, impotence, loss of muscle mass,..."}